Allogene Therapeutics (ALLO) Accounts Payables (2018 - 2026)
Allogene Therapeutics' Accounts Payables was $5.96 million in Q2 2026, up 22.9% from $4.85 million a year earlier and up 20.9% from the prior quarter.
Allogene Therapeutics (ALLO) Accounts Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Allogene Therapeutics came in at $4.27 million, down 20.8% from FY2024.
- Accounts Payables has now declined for three consecutive years, with a five-year compound annual growth rate of -16.3% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $5.39 million in FY2024 (-8.5%), $5.9 million in FY2023 (-57.5%), $13.89 million in FY2022 (+35.4%) and $10.26 million in FY2021 (-1.3%).
- The Q2 2026 figure marks the highest quarterly Accounts Payables since Q2 2024.
- Compared with a year earlier, Accounts Payables was higher in 1 of the last eight quarters, with an average decline of 16.0%.
- The best year-over-year quarter for Accounts Payables over five years was Q1 2023 (growth of 68.7%); the worst was Q2 2025 (a decline of 62.5%).
- Per Business Quant data, ALLO's Accounts Payables in the three quarters before Q2 2026 was $4.93 million (Q1 2026), $4.27 million (Q4 2025) and $3.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Allogene Therapeutics | 435.17 Mn | -666.72 Mn | - | 5.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96 Mn |
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 12.94 Mn |
| Mar 31, 2024 | 5.78 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 6.21 Mn |
| Jun 30, 2023 | 10.23 Mn |
| Mar 31, 2023 | 14.69 Mn |
| Dec 31, 2022 | 13.89 Mn |
| Sep 30, 2022 | 11.05 Mn |
| Jun 30, 2022 | 9.71 Mn |
| Mar 31, 2022 | 8.71 Mn |
| Dec 31, 2021 | 10.26 Mn |
| Sep 30, 2021 | 11.50 Mn |
Allogene Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ALLO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();